Patents by Inventor Jason M. PERRY

Jason M. PERRY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions comprising sorbitan esters
    Patent number: 9351976
    Abstract: The present invention relates to a pharmaceutical composition comprising sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: May 31, 2016
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver
  • PHARMACEUTICAL COMPOSITIONS HAVING IMPROVED STORAGE STABILITY
    Publication number: 20160136279
    Abstract: The present invention relates to a pharmaceutical composition that provides long-term stability of a hydrolytically labile antipsychotic agent
    Type: Application
    Filed: October 13, 2015
    Publication date: May 19, 2016
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver, Michael J. Palmieri, Zhengzheng Pan
  • TIOTROPIUM DRY POWDERS
    Publication number: 20160120855
    Abstract: The present invention relates to respirable dry powder comprising respirable dry particles that comprise sodium chloride, leucine, and tiotropium bromide, wherein the sodium chloride is about 60% to about 90%, the leucine is about 10% to about 40%, the tiotropium bromide is about 0.01% to about 0.5%, and optionally one or more additional therapeutic agents up to about 20%, wherein all percentages are weight percentages on a dry basis and all the components of the respirable dry particles amount to 100%. The invention also relates to respirable dry powders that contain respirable dry particles that comprise sodium chloride, leucine, and tiotropium bromide, wherein the sodium chloride is 67% to 84%, the leucine is 12% to 28%, the tiotropium bromide is about 0.01% to about 0.5%, and optionally one or more additional therapeutic agents up to about 20%, wherein all percentages are weight percentages on a dry basis and all the components of the respirable dry particles amount to 100%.
    Type: Application
    Filed: September 30, 2015
    Publication date: May 5, 2016
    Inventors: Jean C. Sung, Diana Manzanedo, Jason M. Perry, Wesley Dehaan, Brian Trautman
  • CRYSTALLIZATION PROCESS OF ARIPIPRAZOLE DERIVATIVES IN EXTENDED RELEASE FORMULATIONS FOR TREATMENT OF SCHIZOPHRENIA
    Publication number: 20160051546
    Abstract: Processes for providing depot injections of recrystallized aripiprazole lauroxil in which particles of the aripiprazole lauroxil have a surface area of about 0.50 to about 3.3 m2/g; and crystals of aripiprazole lauroxil produced by such processes.
    Type: Application
    Filed: August 24, 2015
    Publication date: February 25, 2016
    Inventors: Wilfredo Morales, JR., Tarek A. Zeidan, Renato A. Chiarella, Steven G. Wright, Jason M. Perry
  • PHARMACEUTICAL COMPOSITIONS COMPRISING SORBITAN ESTERS
    Publication number: 20160038508
    Abstract: The present invention relates to a pharmaceutical composition comprising sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.
    Type: Application
    Filed: April 16, 2015
    Publication date: February 11, 2016
    Inventors: Jason M. PERRY, Daniel R. DEAVER, Magali B. HICKEY, Julius F. REMENAR, Jennifer VANDIVER
  • Pharmaceutical compositions having improved storage stability
    Patent number: 9193685
    Abstract: The present invention relates to a pharmaceutical composition that provides long-term stability of a hydrolytically labile antipsychotic agent
    Type: Grant
    Filed: September 19, 2013
    Date of Patent: November 24, 2015
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver, Michael J. Palmieri, Jr., Zhengzheng Pan
  • PHARMACEUTICAL COMPOSITIONS COMPRISING SORBITAN ESTERS
    Publication number: 20150258115
    Abstract: The present invention relates to a pharmaceutical composition comprising sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.
    Type: Application
    Filed: May 18, 2015
    Publication date: September 17, 2015
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver
  • Pharmaceutical compositions comprising sorbitan esters
    Patent number: 9034867
    Abstract: The present invention relates to a pharmaceutical composition comprising sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.
    Type: Grant
    Filed: March 19, 2012
    Date of Patent: May 19, 2015
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Jason M. Perry, Daniel R. Deaver, Magall B. Hickey, Julius F. Remenar, Jennifer Vandiver
  • PHARMACEUTICAL COMPOSITIONS HAVING IMPROVED STORAGE STABILITY
    Publication number: 20140088115
    Abstract: The present invention relates to a pharmaceutical composition that provides long-term stability of a hydrolytically labile antipsychotic agent
    Type: Application
    Filed: September 19, 2013
    Publication date: March 27, 2014
    Applicant: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver, Michael J. Palmieri, JR., Zhengzheng Pan
  • PHARMACEUTICAL COMPOSITIONS COMPRISING FATTY GLYCEROL ESTERS
    Publication number: 20130267504
    Abstract: The present invention relates to a pharmaceutical composition comprising glycerol esters of a fatty acid, wherein the compositions are useful for the delivery of anti-psychotic drugs.
    Type: Application
    Filed: March 13, 2013
    Publication date: October 10, 2013
    Applicant: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Jason M. PERRY, Magali B. HICKEY, Julius F. REMENAR, Jennifer VANDIVER
  • PHARMACEUTICAL COMPOSITIONS COMPRISING FATTY ACID ESTERS
    Publication number: 20130267503
    Abstract: The present invention relates to an injectable, pharmaceutical composition comprising a C1-6 alkyl ester of a C10-20 fatty acid. In an embodiment, the fatty acid is ethyl oleate, isopropyl oleate, ethyl myristate, or isopropyl myristate. These compositions are useful for the delivery of anti-psychotic drugs.
    Type: Application
    Filed: March 13, 2013
    Publication date: October 10, 2013
    Applicant: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Jason M. PERRY, Magali B. HICKEY, Julius F. REMENAR, Jennifer VANDIVER
  • PHARMACEUTICAL COMPOSITIONS COMPRISING BENZYL ALCOHOL
    Publication number: 20130267505
    Abstract: The present invention relates to a pharmaceutical composition comprising benzyl alcohol and polyoxyethylene derivatives of sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.
    Type: Application
    Filed: March 13, 2013
    Publication date: October 10, 2013
    Applicant: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Jason M. PERRY, Magali B. HICKEY, Julius F. REMENAR, Jennifer VANDIVER
  • PHARMACEUTICAL COMPOSITIONS COMPRISING SORBITAN ESTERS
    Publication number: 20120238552
    Abstract: The present invention relates to a pharmaceutical composition comprising sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.
    Type: Application
    Filed: March 19, 2012
    Publication date: September 20, 2012
    Applicant: ALKERMES, INC.
    Inventors: Jason M. PERRY, Daniel R. DEAVER, Magall B. HICKEY, Julius F. REMENAR, Jennifer VANDIVER